256 related articles for article (PubMed ID: 21392207)
1. Screening for prostate cancer: an updated Cochrane systematic review.
Ilic D; O'Connor D; Green S; Wilt TJ
BJU Int; 2011 Mar; 107(6):882-91. PubMed ID: 21392207
[TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer.
Ilic D; O'Connor D; Green S; Wilt T
Cochrane Database Syst Rev; 2006 Jul; (3):CD004720. PubMed ID: 16856057
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
Hayes JH; Barry MJ
JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
Ilic D; Djulbegovic M; Jung JH; Hwang EC; Zhou Q; Cleves A; Agoritsas T; Dahm P
BMJ; 2018 Sep; 362():k3519. PubMed ID: 30185521
[TBL] [Abstract][Full Text] [Related]
7. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
Pron G
Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer: a Cochrane systematic review.
Ilic D; O'Connor D; Green S; Wilt T
Cancer Causes Control; 2007 Apr; 18(3):279-85. PubMed ID: 17206534
[TBL] [Abstract][Full Text] [Related]
9. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.
Wilt TJ; Macdonald R; Hagerty K; Schellhammer P; Tacklind J; Somerfield MR; Kramer BS
BJU Int; 2010 Nov; 106(10):1444-51. PubMed ID: 20977593
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
[TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
Lin K; Lipsitz R; Miller T; Janakiraman S;
Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846
[TBL] [Abstract][Full Text] [Related]
12. PSA-based screening for prostate cancer. Too many adverse effects.
Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259
[TBL] [Abstract][Full Text] [Related]
13. Lycopene for the prevention of prostate cancer.
Ilic D; Forbes KM; Hassed C
Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD008007. PubMed ID: 22071840
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]